These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 11684312)
1. The response of hepatitis C virus and TT virus to high dose and long duration interferon-alpha therapy in naïve chronic hepatitis C patients. Dai CY; Yu ML; Chuang WL; Hou NJ; Hou C; Chen SC; Lin ZY; Hsieh MY; Wang LY; Chang WY Antiviral Res; 2002 Jan; 53(1):9-18. PubMed ID: 11684312 [TBL] [Abstract][Full Text] [Related]
2. Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to alpha-interferon. Nishizawa Y; Tanaka E; Orii K; Rokuhara A; Ichijo T; Yoshizawa K; Kiyosawa K J Gastroenterol Hepatol; 2000 Nov; 15(11):1292-7. PubMed ID: 11129224 [TBL] [Abstract][Full Text] [Related]
3. Effect of TT virus co-infection on interferon response in chronic hepatitis C patients. Kawanaka M; Niiyama G; Mahmood S; Ifukube S; Yoshida N; Onishi H; Hanano S; Ito T; Yamada G Liver; 2002 Aug; 22(4):351-5. PubMed ID: 12296969 [TBL] [Abstract][Full Text] [Related]
4. Clinical implications of TT virus superinfection in patients with chronic hepatitis C. Watanabe H; Saito T; Kawamata O; Shao L; Aoki M; Terui Y; Mitsuhashi H; Matsuo T; Takeda Y; Saito K; Togashi H; Shinzawa H; Takahashi T Am J Gastroenterol; 2000 Jul; 95(7):1776-80. PubMed ID: 10925984 [TBL] [Abstract][Full Text] [Related]
5. Influence of transfusion-transmitted virus infection on the clinical features and response to interferon therapy in Japanese patients with chronic hepatitis C. Hagiwara H; Hayashi N; Mita E; Oshita M; Kobayashi I; Iio S; Hiramatsu N; Sasaki Y; Kasahara A; Kakinuma K; Yamauchi T; Fusamoto H J Viral Hepat; 1999 Nov; 6(6):463-9. PubMed ID: 10607265 [TBL] [Abstract][Full Text] [Related]
6. Relationships between TT virus infection and hepatitis C virus response to interferon therapy in doubly infected patients. Maggi F; Fornai C; Tempestini E; Andreoli E; Lanini L; Vatteroni ML; Pistello M; Marchi S; Antonelli G; Bendinelli M J Biol Regul Homeost Agents; 2003; 17(2):176-82. PubMed ID: 14518719 [TBL] [Abstract][Full Text] [Related]
7. Response of TT virus to IFN plus ribavirin treatment in patients with chronic hepatitis C. Moreno J; Moraleda G; Barcena R; Mateos M; del Campo S World J Gastroenterol; 2004 Jan; 10(1):143-6. PubMed ID: 14695786 [TBL] [Abstract][Full Text] [Related]
8. [Viral co-infections in hepatitis C: HBV, HBV-C/HGV and TTV studies]. Pár A; Takács M; Brojnás J; Berencsi G; Paál M; Horányi M; Miseta A; Hegedüs G; Mózsik G; Hunyady B Orv Hetil; 2004 May; 145(19):987-92. PubMed ID: 15181733 [TBL] [Abstract][Full Text] [Related]
9. TT virus infection in patients with chronic hepatitis C virus infection--effect of primers, prevalence, and clinical significance. Hepatitis Interventional Therapy Group. Mizokami M; Albrecht JK; Kato T; Orito E; Lai VC; Goodman Z; Hong Z; Lau JY J Hepatol; 2000 Feb; 32(2):339-43. PubMed ID: 10707876 [TBL] [Abstract][Full Text] [Related]
10. Influence of TT virus co-infection on IFN-beta therapy in patients with chronic hepatitis C. Yamada T; Naitou H; Morita T Kansenshogaku Zasshi; 2002 Sep; 76(9):747-53. PubMed ID: 12391678 [TBL] [Abstract][Full Text] [Related]
11. Interferon treatment of two patients with quadruple infection with hepatitis C virus (HCV), human immunodeficiency virus (HIV), hepatitis G virus (HGV), and TT virus (TTV). Toyoda H; Fukuda Y; Yokozaki S; Nakano I; Hayakawa T; Takamatsu J Liver; 1999 Oct; 19(5):438-43. PubMed ID: 10533804 [TBL] [Abstract][Full Text] [Related]
12. High TT virus load as an independent factor associated with the occurrence of hepatocellular carcinoma among patients with hepatitis C virus-related chronic liver disease. Tokita H; Murai S; Kamitsukasa H; Yagura M; Harada H; Takahashi M; Okamoto H J Med Virol; 2002 Aug; 67(4):501-9. PubMed ID: 12115995 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of TT virus in chronic hepatitis C. Meng XW; Komatsu M; Goto T; Nakane K; Ohshima S; Yoneyama K; Lin JG; Watanabe S J Gastroenterol Hepatol; 2001 Feb; 16(2):202-8. PubMed ID: 11207902 [TBL] [Abstract][Full Text] [Related]
14. The prevalence of TT virus and GB virus C/hepatitis G virus infection in individuals with raised liver enzymes but without HBV or HCV infection in Taiwan. Dai CY; Yu ML; Chang WY; Tseng CH; Hou C; Lin ZY; Chen SC; Hsieh MY; Wang LY; Tsai JF; Chuang WL Epidemiol Infect; 2002 Oct; 129(2):307-13. PubMed ID: 12403107 [TBL] [Abstract][Full Text] [Related]
15. Effect of interferon on a nonenveloped DNA virus (TT virus) associated with acute and chronic hepatitis of unknown etiology. Akahane Y; Sakamoto M; Miyazaki Y; Okada S; Inoue T; Ukita M; Okamoto H; Miyakawa Y; Mayumi M J Med Virol; 1999 Jul; 58(3):196-200. PubMed ID: 10447412 [TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and distribution of genotypes of TT virus infection in a hepatitis C virus-hyperendemic township of a hepatitis B virus-endemic country (Taiwan). Dai CY; Yu ML; Hou C; Lu SN; Wang JH; Huang JF; Chen SC; Lin ZY; Hsieh MY; Tsai JF; Wang LY; Chuang WL; Chang WY J Gastroenterol Hepatol; 2002 Nov; 17(11):1192-7. PubMed ID: 12453279 [TBL] [Abstract][Full Text] [Related]
17. TT virus infection in patients with chronic hepatitis B or C: influence on clinical, histological and virological features. Kao JH; Chen W; Chen PJ; Lai MY; Chen DS J Med Virol; 2000 Apr; 60(4):387-92. PubMed ID: 10686020 [TBL] [Abstract][Full Text] [Related]
18. TT virus infection in Italy: prevalence and genotypes in healthy subjects, viral liver diseases and asymptomatic infections by parenterally transmitted viruses. Masia G; Ingianni A; Demelia L; Faa G; Manconi PE; Pilleri G; Ciancio A; Rizzetto M; Coppola RC J Viral Hepat; 2001 Sep; 8(5):384-90. PubMed ID: 11555197 [TBL] [Abstract][Full Text] [Related]
19. Epidemiology and clinical significance of chronic hepatitis-related viruses infection in hemodialysis patients from Taiwan. Dai CY; Yu ML; Chuang WL; Sung MH; Lin ZY; Chen SC; Hsieh MY; Wang LY; Tsai JF; Chang WY Nephron; 2002 Feb; 90(2):148-53. PubMed ID: 11818698 [TBL] [Abstract][Full Text] [Related]
20. Viral and host factors in the prediction of response to interferon-alpha therapy in chronic hepatitis C after long-term follow-up. Knolle PA; Kremp S; Höhler T; Krummenauer F; Schirmacher P; Gerken G J Viral Hepat; 1998 Nov; 5(6):399-406. PubMed ID: 9857349 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]